The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine

Cancer Chemotherapy and Pharmacology

Volumn 37, Issue 5, 1996, Pages 479-485

  Hogarth, Linda ^a   English, Martin ^b   Price, Lisa ^b   Wyllie, Ruth ^b   Pearson, Andrew D J ^b   Hall, Andrew G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Carboplatin; Cisplatin; Cytotoxic chemotherapy; Glutathione; Melphalan; Nephrotoxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; GLUTATHIONE; MELPHALAN;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; ERYTHROCYTE; HUMAN; MONONUCLEAR CELL; NEPHROTOXICITY; PRIORITY JOURNAL; URINE LEVEL;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BLOOD CELLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; CISPLATIN; ERYTHROCYTES; GLUTATHIONE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MELPHALAN; NEOPLASMS; REFERENCE VALUES; TIME FACTORS;

EID: 0030041340     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050415     Document Type: Article

References (38)

1. Stevens JL, Jones DP (1989) The mercapturic acid pathway: biosynthesis, intermediary metabolism, and physiological disposition. In: Dolphin D, Avramovic O, Poulson R (eds) Glutathione, Chemical, biochemical, and medical aspects, Wiley, New York, p 45
2. Ahmad S, Okine L, Le B, Najarian P, Vistica DT (1987) Elevation of glutathione in phenylalanine mustard-resistant murine L1210 leukemia cells. J Biol Chem 262: 15048
3. Hospers GA, Mulder NH, Jong B de, Ley L de, Uges DR, Fichtinger Schepman AM, Scheper RJ, Vries EG de (1988) Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro. Cancer Res 48: 6803
4. Zunino F, Tofanetti O, Besati A, Cavalletti E, Savi G (1983) Protective effect of reduced glutathione against cis-dichlorodiammine platinum (II)-induced nephrotoxicity and lethal toxicity. Tumori 69: 105.
5. Oriana S, Bohm S, Spatti G, Zunino F, Di Re F (1987) A preliminary clinical experience with reduced glutathione as protector against cisplatin toxicity. Tumori 73: 337
6. Anderson ME, Naganuma A, Meister A (1990) Protection against cisplatin toxicity by administration of glutathione ester. FASEB J 4: 3251
7. Ishikawa M, Takayanagi Y, Sasaki K (1990) The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice. Jpn J Pharmacol 52: 652
8. Appenroth D, Winnefeld K (1993) Role of glutathione for cis-platin nephrotoxicity in young and adult ruts. Ren Fail 15: 135
9. Chang M, Shi M, Forman HJ (1992) Exogenous glutathione protects endothelial cells from menadione toxicity. Am J Physiol 262: L637
10. Rajpert De Meyts E, Shi M, Chang M, Robison TW, Groffen J, Heisterkamp N, Forman HJ (1992) Transfection with gamma-glutamyl transpeptidase enhances recovery from glutathione depletion using extracellular glutathione. Toxicol Appl Pharmacol 114: 56
11. Nakano S, Gemba M (1989) Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn J Pharmacol 50: 87
12. Muller MR, Wright KA, Twentyman PR (1991) Differential properties of cisplatin and tetraplatin with respect to cytotoxicity and perturbation of cellular glutathione levels. Cancer Chemother Pharmacol 28: 273
13. Adams DJ, Carmichael J, Wolf CR (1985) Altered mouse bone marrow glutathione and glutathione transferase levels in response to cytotoxins. Cancer Res 45: 1669
14. Millar JL, Hudspith BN, Blackett NM (1975) Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulfan. Br J Cancer 32: 193
15. Hedley DW, Millar JL, McElwain TJ, Gordon MY (1978) Acceleration of bone-marrow recovery by pre-treatment with cyclophosphamide in patients receiving high-dose melphalan. Lancet 2: 966
16. Lind MJ, McGown AT, Hadfield JA, Thatcher N, Crowther D, Fox BW (1989) The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochem Pharmacol 38: 1835
17. Gordon SJ, Pearson ADJ, Reid MM, Craft AW (1992) Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer 28A: 1319
18. Corbett R, Pinkerton R, Pritchard J, Mellor S, Lewis I, Kingston J, McElwain T (1992) Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer 28A: 1324
19. Colgreave IA, Moldeus P (1986) Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems. J Biochem Biophys Methods 13: 231
20. Anderson ME (1985) Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113: 548
21. Neuschwander-Tetri BA, Roll FJ (1989) Glutathione measurement by high-performance liquid chromatography separation and fluorometric detection of the glutathione-orthophthaldehyde adduct. Anal Biochem 179: 236
22. Russo A, Carmichael J, Friedman N, DeGraff W, Tochner Z, Glatstein E, Mitchell JB (1986) The roles of intracellular glulathione in antineoplastic chemotherapy. Int J Radiat Oncol Biol Phys 12: 1347
23. Ripple M, Mulcahy RT, Wilding G (1993) Characteristics of the glutathione glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells. J Urol 150: 209
24. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR (1991) The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br J Cancer 64: 215
25. Bailey HH, Gipp JJ, Ripple M, Wilding G, Mulcahy RT (1992) Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels. Cancer Res 52: 5115
26. Ahmad S, Okine L, Wood R, Aljian J, Vistica DT (1987) Gamma-glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents. J Cell Physiol 131: 240
27. Barranco SC, Townsend CMJ, Weintraub B, Beasley EG, MacLean KK, Shaeffer J, Liu NH, Schellenberg K (1990) Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro. Cancer Res 50: 3614
28. Zunino F, Pratesi G, Micheloni A, Cavalletti E, Sala F, Tofanetti O (1989) Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem Biol Interact 70: 89
29. Beutler E, Gelbart T (1985) Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105: 581
30. Svardal AM, Mansoor MA, Ueland PM (1990) Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal Biochem 184: 338
31. Mansoor MA, Svardal AM, Ueland PM (1992) Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 200: 218
32. Chauhan DP, Gupta PH, Nampoothiri MRN, Singhal PC, Chugh KS, Nair CR (1982) Determination of erythrocyte dismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malonyldialdehyde in uremia. Clin Chim Acta 123: 153
33. Nishiyama J, Kuninori T (1984) Assay of biological thiols by a combination of high-performance liquid chromatography and post column reaction with 6,6′-dithiodinicotinic acid. Anal Biochem 138: 95
34. Kosower NS, Kosower EM (1978) The glutathione status of cells. Int Rev Cytol 54: 109
35. Tilby MJ, Newell DR, Viner C, Selby PJ, Dean CJ (1993) Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapy. Eur J Cancer 29A: 681
36. Tilby MJ, Johnson C, Knox RJ, Cordell J, Roberts JJ, Dean CJ (1991) Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody. Cancer Res 51: 123
37. Meister A (1989) Metabolism and function of glutathione. In: Dolphin D, Poulson R, Avramovic O (eds) Glutathione: chemical, biochemical and medical aspects. Wiley, New York, p 367
38. Dedon PC, Borch RF (1987) Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles. Biochem Pharmacol 36: 1955